The associations of multimorbidity with the sum of annual medical and long-term care expenditures in Japan.
Charlson comorbidity index
Claims data
Long-term care expenditures
Medical expenditures
Multimorbidity
Journal
BMC geriatrics
ISSN: 1471-2318
Titre abrégé: BMC Geriatr
Pays: England
ID NLM: 100968548
Informations de publication
Date de publication:
07 03 2019
07 03 2019
Historique:
received:
14
10
2018
accepted:
06
02
2019
entrez:
8
3
2019
pubmed:
8
3
2019
medline:
14
1
2020
Statut:
epublish
Résumé
The occurrence of multimorbidity (i.e., the coexistence of multiple chronic diseases) increases with age in older adults and is a growing concern worldwide. Multimorbidity has been reported to be a driving factor in the increase of medical expenditures in OECD countries. However, to the best of our knowledge, there is no published research that has examined the associations between multimorbidity and either long-term care (LTC) expenditure or the sum of medical and LTC expenditures worldwide. We, therefore, aimed to examine the associations of multimorbidity with the sum of medical and LTC expenditures for older adults in Japan. Medical insurance claims data for adults ≥75 years were merged with LTC insurance claims data from Kashiwa city, a suburb in the Tokyo metropolitan area, for the period between April 2012 and September 2013 to obtain an estimate of medical and LTC expenditures. We also calculated the 2011 updated and reweighted version of the Charlson Comorbidity Index (CCI) scores. Then, we performed multiple generalized linear regressions to examine the associations of CCI scores (0, 1, 2, 3, 4, or ≥ 5) with the sum of annual medical and LTC expenditures, adjusting for age, sex, and household income level. The mean sum of annual medical and LTC expenditures was ¥1,086,000 (US$12,340; n = 30,042). Medical and LTC expenditures accounted for 66 and 34% of the sum, respectively. Every increase in one unit of the CCI scores was associated with a ¥257,000 (US$2920); 95% Confidence Interval: ¥242,000, 271,000 (US$2750, 3080) increase in the sum of the expenditures (p < 0.001; n = 29,915). Using a merged medical and LTC claims dataset, we found that greater CCI scores were associated with a higher sum of annual medical and LTC expenditures for older adults. To the best of our knowledge, this is the first study to examine the associations of multimorbidity with LTC expenditures or the sum of medical and LTC expenditures worldwide. Our study indicated that the economic burden on society caused by multimorbidity could be better evaluated by the sum of medical and LTC expenditures, rather than medical expenditures alone.
Sections du résumé
BACKGROUND
The occurrence of multimorbidity (i.e., the coexistence of multiple chronic diseases) increases with age in older adults and is a growing concern worldwide. Multimorbidity has been reported to be a driving factor in the increase of medical expenditures in OECD countries. However, to the best of our knowledge, there is no published research that has examined the associations between multimorbidity and either long-term care (LTC) expenditure or the sum of medical and LTC expenditures worldwide. We, therefore, aimed to examine the associations of multimorbidity with the sum of medical and LTC expenditures for older adults in Japan.
METHODS
Medical insurance claims data for adults ≥75 years were merged with LTC insurance claims data from Kashiwa city, a suburb in the Tokyo metropolitan area, for the period between April 2012 and September 2013 to obtain an estimate of medical and LTC expenditures. We also calculated the 2011 updated and reweighted version of the Charlson Comorbidity Index (CCI) scores. Then, we performed multiple generalized linear regressions to examine the associations of CCI scores (0, 1, 2, 3, 4, or ≥ 5) with the sum of annual medical and LTC expenditures, adjusting for age, sex, and household income level.
RESULTS
The mean sum of annual medical and LTC expenditures was ¥1,086,000 (US$12,340; n = 30,042). Medical and LTC expenditures accounted for 66 and 34% of the sum, respectively. Every increase in one unit of the CCI scores was associated with a ¥257,000 (US$2920); 95% Confidence Interval: ¥242,000, 271,000 (US$2750, 3080) increase in the sum of the expenditures (p < 0.001; n = 29,915).
CONCLUSIONS
Using a merged medical and LTC claims dataset, we found that greater CCI scores were associated with a higher sum of annual medical and LTC expenditures for older adults. To the best of our knowledge, this is the first study to examine the associations of multimorbidity with LTC expenditures or the sum of medical and LTC expenditures worldwide. Our study indicated that the economic burden on society caused by multimorbidity could be better evaluated by the sum of medical and LTC expenditures, rather than medical expenditures alone.
Identifiants
pubmed: 30841859
doi: 10.1186/s12877-019-1057-7
pii: 10.1186/s12877-019-1057-7
pmc: PMC6404301
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
69Références
Hypertens Res. 2010 Aug;33(8):802-7
pubmed: 20505676
Arch Osteoporos. 2018 Mar 30;13(1):37
pubmed: 29603078
Hypertens Res. 2005 Nov;28(11):859-64
pubmed: 16555573
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Eur J Health Econ. 2018 Jul;19(6):831-842
pubmed: 28856487
Ageing Res Rev. 2011 Sep;10(4):430-9
pubmed: 21402176
J Health Econ. 2011 Mar;30(2):425-38
pubmed: 21295364
Health Serv Res. 2010 Apr;45(2):532-52
pubmed: 20132341
J Health Econ. 2000 Sep;19(5):679-95
pubmed: 11184799
PLoS One. 2014 Dec 03;9(12):e112479
pubmed: 25469987
BMC Health Serv Res. 2011 May 17;11:103
pubmed: 21575260
Int J Environ Res Public Health. 2010 Aug;7(8):3022-37
pubmed: 20948944
Am J Epidemiol. 2011 Mar 15;173(6):676-82
pubmed: 21330339
J Gerontol A Biol Sci Med Sci. 2019 Jan 16;74(2):211-218
pubmed: 29596617
Int J Qual Health Care. 2002 Aug;14(4):295-303
pubmed: 12201188
BMC Health Serv Res. 2012 Jun 19;12:165
pubmed: 22713212
Int J Qual Health Care. 2014 Feb;26(1):79-86
pubmed: 24225269
Med Care. 2005 Nov;43(11):1130-9
pubmed: 16224307
Lancet. 2011 Sep 17;378(9796):1106-15
pubmed: 21885107
Lancet. 2011 Sep 24;378(9797):1183-92
pubmed: 21885099
J Epidemiol. 2019 Oct 5;29(10):377-383
pubmed: 30249946
Health Policy. 2015 Jun;119(6):840-9
pubmed: 25467791